Avalo Therapeutics Announces Key Developments and Financial Overview for Q1 2025
May 12, 2025 - 14:37
Mike Heffernan has been appointed as the new Chairman of the Board at Avalo Therapeutics, marking a significant leadership change for the company. In addition to this appointment, the company is anticipating the release of topline data from its Phase 2 LOTUS trial for AVTX-009, a treatment aimed at addressing hidradenitis suppurativa, with results expected in 2026.
As of March 31, 2025, Avalo reported a robust cash position of approximately $125 million, which is projected to provide sufficient financial runway into 2027. This funding will allow the company to continue its focus on developing innovative therapies for immune dysregulation, with the potential to extend operations into 2028 if necessary.
These updates reflect Avalo's commitment to advancing its clinical programs and enhancing shareholder value as it navigates the complexities of the biotechnology landscape. The leadership transition and solid financial standing position the company for future growth and success in the coming years.
MORE NEWS
June 28, 2025 - 02:52
Arrest Made in Connection to Alleged Prostitution at Foot SpaDeputies in Putnam County have arrested and charged a woman following the execution of a search warrant that uncovered illegal commercial sex activities at a purported foot spa. Authorities...
June 27, 2025 - 03:33
Business Leaders Rally Behind Eric Adams Amid Concerns Over Mamdani's SurgeProminent figures in New York City`s business community, including hedge fund manager Daniel Loeb, are expressing alarm over the rising popularity of Zohran Mamdani in the Democratic mayoral...
June 26, 2025 - 10:13
Power Outages Continue to Impact Littlestown Small BusinessesAs power outages drag through their fourth day, small businesses, like Littlestown`s Firehouse Grill, are thankful for the community`s support. The prolonged disruption has left many local...
June 25, 2025 - 22:27
Whole Foods Leader Critiques Bureaucracy in Internal MeetingJason Buechel is embracing Amazon`s mission to cut red tape across the company. He did not mince words in a recent meeting with grocery staff, where he expressed frustration over the excessive...